Riskpilot← Back to searchSign inGet full accessMoreira Neurology AB
ABActiveOrg 5569764961Docentbacken 5Medical specialists activities · NACE 8622Est. 20140 employees
Revenue 2024
SEK 824K
+324% vs 2023
EBITDA margin
38.3%
+6226% vs 2023
Equity ratio
61.1%
Financial strength
Net profit 2024
SEK 294K
+6788% vs 2023
| Revenue | SEK 824K | +324% |
| EBITDA | SEK 316K | +6226% |
| Net profit | SEK 294K | +6788% |
| Total assets | SEK 858K | +96% |
| Equity | SEK 524K | +128% |
| Employees | 0 | — |
Legal name
Moreira Neurology AB
Org number
5569764961
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 juli 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten Registrerad särskild delgivningsmottagare saknas. Då minst halva antalet styrelseledamöter, minst halva antalet styrelsesuppleanter och minst en särskild firmatecknare ska vara bosatta inom EES uppfyller företaget inte kravet på bosättning.
Company purpose
Föremålet för bolagets verksamhet är konsultverksamhet inom neurologi och därmed förenlig verksamhet.
Address
Docentbacken 5
Email
tiago.more@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 79 | 160 | 110 | 194 | 824 |
| Staff expenses | — | — | — | −13 | −8 |
| EBITDA | 3 | 127 | 5 | 5 | 316 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 3 | 127 | 5 | 5 | 316 |
| Net financials | −3 | −2 | −1 | −5 | −4 |
| Profit before tax | 0 | 95 | 4 | −0 | 373 |
| Tax | −1 | −20 | −2 | −4 | −78 |
| Net profit | −1 | 75 | 3 | −4 | 294 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 308 | 435 | 377 | 438 | 858 |
| Equity | 157 | 232 | 309 | 230 | 524 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 121 | 142 | 82 | 147 | 334 |
| Total debt | 121 | 142 | 82 | 147 | 334 |
EBITDA margin
38.3%
This company
15.8%
Market median
+142% vs market
20202024
Equity ratio
61.1%
This company
38.2%
Market median
+60% vs market
20202024
Return on equity
56.1%
This company
18.4%
Market median
+205% vs market
20202024
Net profit margin
35.7%
This company
8.1%
Market median
+341% vs market
20202024
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LH Audit | Audit | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Moreira Neurology AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Håkan Uddström | Audit | 0 companies |
| Lisa Maria Isabella Holm Moreira | Deputy Board Member | 0 companies |
| Tiago Jorge Holm Moreira | Board of Directors | 0 companies |